StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 07 Aug 2026 17:29:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form 144 Anika Therapeutics, Inc. Filed by: Jellison William R http://www.streetinsider.com/SEC+Filings/Form++144++++++++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Jellison+William+R/26892308.html si-local-file:///var/storage/secattach/20260807/26892308.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Jellison+William+R/26892308.html Fri, 07 Aug 2026 17:29:00 -0400 ANIK O.00173818 Form 144 Anika Therapeutics, Inc. Filed by: Jellison William R http://www.streetinsider.com/SEC+Filings/Form++144++++++++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Jellison+William+R/26892308.html si-local-file:///var/storage/secattach/20260807/26892308.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Jellison+William+R/26892308.html Fri, 07 Aug 2026 17:29:00 -0400 ANIK O.00173818 Form 4 Anika Therapeutics, Inc. For: Aug 03 Filed by: Fischetti Gary P http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Aug+03++Filed+by%3A+Fischetti+Gary+P/26875032.html si-local-file:///var/storage/secattach/20260805/26875032.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Aug+03++Filed+by%3A+Fischetti+Gary+P/26875032.html Wed, 05 Aug 2026 16:30:00 -0400 ANIK O.00173818 Form 4 Anika Therapeutics, Inc. For: Aug 03 Filed by: Fischetti Gary P http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Aug+03++Filed+by%3A+Fischetti+Gary+P/26875032.html si-local-file:///var/storage/secattach/20260805/26875032.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Aug+03++Filed+by%3A+Fischetti+Gary+P/26875032.html Wed, 05 Aug 2026 16:30:00 -0400 ANIK O.00173818 Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox<sup>®</sup> created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ Form SCHEDULE 13G/A Anika Therapeutics, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+VANGUARD+CAPITAL+MANAGEMENT+LLC/26848000.html si-local-file:///var/storage/secattach/20260731/26848000.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+VANGUARD+CAPITAL+MANAGEMENT+LLC/26848000.html Fri, 31 Jul 2026 09:56:00 -0400 ANIK O.00173818